{"title":"Barrett Universal II与Ladas Super Formula在人工晶状体度数计算中的比较。","authors":"Ionela-Iasmina Yasar, Servet Yasar, Leila Al Barri, Nadina Mercea, Mihnea Munteanu, Horia Tudor Stanca","doi":"10.3390/jcm14062023","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Pursuing optimal visual outcomes following cataract surgery remains a cornerstone of modern ophthalmology. Central to this objective is the precise calculation of intraocular lens power. However, despite significant advancements in biometric measurements and computational algorithms, variability in refractive outcomes continues to pose a challenge. This study aims to analyze the outcomes comprehensively by reviewing established and newer techniques. <b>Methods:</b> The eyes included in this study were evaluated based on various criteria, and a total of 210 eyes which met these criteria were included in the research. Our study is a retrospectively designed observational research study. The study included individuals who had experienced successful IOL implantation to correct refractive errors or cataracts. The ARGOS SS-OCT device, a spectral-domain optical coherence tomography system, was used in this study. In measuring the lens power, values were obtained using the Barrett Universal II and Ladas Super Formulas. These values were compared. Postoperative assessments were conducted at 1-3 months and 3-12 months, including spherical equivalents. <b>Results:</b> The mean age of the participants was 63.44 ± 11.62 years. The study's two most frequently used lens brands were ALCON and ZEISS. The lens powers calculated using the Barrett Universal II and Ladas Super Formulas were compared. The mean values calculated using both formulas were highly similar, with no statistically significant differences observed. We compared the spherical equivalent values calculated during the participants' first and second postoperative follow-ups. The spherical equivalent values were similar, with no statistically significant differences. <b>Conclusions:</b> Formulas represent significant advances in ophthalmology and significantly improve visual outcomes; however, differences in their methodology and predictive accuracy warrant further analysis.</p>","PeriodicalId":15533,"journal":{"name":"Journal of Clinical Medicine","volume":"14 6","pages":""},"PeriodicalIF":3.0000,"publicationDate":"2025-03-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11943434/pdf/","citationCount":"0","resultStr":"{\"title\":\"Comparison of Traditional and AI-Based Methods: Barrett Universal II vs. Ladas Super Formula in IOL Power Calculation.\",\"authors\":\"Ionela-Iasmina Yasar, Servet Yasar, Leila Al Barri, Nadina Mercea, Mihnea Munteanu, Horia Tudor Stanca\",\"doi\":\"10.3390/jcm14062023\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p><b>Background:</b> Pursuing optimal visual outcomes following cataract surgery remains a cornerstone of modern ophthalmology. Central to this objective is the precise calculation of intraocular lens power. However, despite significant advancements in biometric measurements and computational algorithms, variability in refractive outcomes continues to pose a challenge. This study aims to analyze the outcomes comprehensively by reviewing established and newer techniques. <b>Methods:</b> The eyes included in this study were evaluated based on various criteria, and a total of 210 eyes which met these criteria were included in the research. Our study is a retrospectively designed observational research study. The study included individuals who had experienced successful IOL implantation to correct refractive errors or cataracts. The ARGOS SS-OCT device, a spectral-domain optical coherence tomography system, was used in this study. In measuring the lens power, values were obtained using the Barrett Universal II and Ladas Super Formulas. These values were compared. Postoperative assessments were conducted at 1-3 months and 3-12 months, including spherical equivalents. <b>Results:</b> The mean age of the participants was 63.44 ± 11.62 years. The study's two most frequently used lens brands were ALCON and ZEISS. The lens powers calculated using the Barrett Universal II and Ladas Super Formulas were compared. The mean values calculated using both formulas were highly similar, with no statistically significant differences observed. We compared the spherical equivalent values calculated during the participants' first and second postoperative follow-ups. The spherical equivalent values were similar, with no statistically significant differences. <b>Conclusions:</b> Formulas represent significant advances in ophthalmology and significantly improve visual outcomes; however, differences in their methodology and predictive accuracy warrant further analysis.</p>\",\"PeriodicalId\":15533,\"journal\":{\"name\":\"Journal of Clinical Medicine\",\"volume\":\"14 6\",\"pages\":\"\"},\"PeriodicalIF\":3.0000,\"publicationDate\":\"2025-03-17\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11943434/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Clinical Medicine\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3390/jcm14062023\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MEDICINE, GENERAL & INTERNAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/jcm14062023","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
摘要
背景:追求白内障手术后的最佳视力结果仍然是现代眼科学的基石。这个目标的核心是精确计算人工晶状体的度数。然而,尽管生物测量和计算算法取得了重大进展,屈光结果的可变性仍然是一个挑战。本研究旨在通过回顾现有的和较新的技术来全面分析结果。方法:本研究纳入的眼睛根据各种标准进行评估,符合这些标准的共210只眼睛被纳入研究。我们的研究是回顾性设计的观察性研究。研究对象包括成功植入人工晶体以矫正屈光不正或白内障的患者。本研究使用ARGOS SS-OCT设备,一种光谱域光学相干层析成像系统。在测量透镜功率时,使用巴雷特通用II和拉达斯超级公式获得数值。对这些值进行比较。术后评估分别在1-3个月和3-12个月进行,包括球形当量。结果:参与者平均年龄为63.44±11.62岁。研究中使用频率最高的两个镜片品牌是爱尔康和蔡司。比较使用Barrett Universal II和Ladas Super formula计算的透镜功率。使用两种公式计算的平均值非常相似,没有观察到统计学上的显著差异。我们比较了参与者第一次和第二次术后随访期间计算的球形等效值。球面等效值相似,无统计学差异。结论:配方代表了眼科的重大进步,显著改善了视力;然而,他们在方法和预测准确性方面的差异值得进一步分析。
Comparison of Traditional and AI-Based Methods: Barrett Universal II vs. Ladas Super Formula in IOL Power Calculation.
Background: Pursuing optimal visual outcomes following cataract surgery remains a cornerstone of modern ophthalmology. Central to this objective is the precise calculation of intraocular lens power. However, despite significant advancements in biometric measurements and computational algorithms, variability in refractive outcomes continues to pose a challenge. This study aims to analyze the outcomes comprehensively by reviewing established and newer techniques. Methods: The eyes included in this study were evaluated based on various criteria, and a total of 210 eyes which met these criteria were included in the research. Our study is a retrospectively designed observational research study. The study included individuals who had experienced successful IOL implantation to correct refractive errors or cataracts. The ARGOS SS-OCT device, a spectral-domain optical coherence tomography system, was used in this study. In measuring the lens power, values were obtained using the Barrett Universal II and Ladas Super Formulas. These values were compared. Postoperative assessments were conducted at 1-3 months and 3-12 months, including spherical equivalents. Results: The mean age of the participants was 63.44 ± 11.62 years. The study's two most frequently used lens brands were ALCON and ZEISS. The lens powers calculated using the Barrett Universal II and Ladas Super Formulas were compared. The mean values calculated using both formulas were highly similar, with no statistically significant differences observed. We compared the spherical equivalent values calculated during the participants' first and second postoperative follow-ups. The spherical equivalent values were similar, with no statistically significant differences. Conclusions: Formulas represent significant advances in ophthalmology and significantly improve visual outcomes; however, differences in their methodology and predictive accuracy warrant further analysis.
期刊介绍:
Journal of Clinical Medicine (ISSN 2077-0383), is an international scientific open access journal, providing a platform for advances in health care/clinical practices, the study of direct observation of patients and general medical research. This multi-disciplinary journal is aimed at a wide audience of medical researchers and healthcare professionals.
Unique features of this journal:
manuscripts regarding original research and ideas will be particularly welcomed.JCM also accepts reviews, communications, and short notes.
There is no limit to publication length: our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible.